A Look at the Major Technical Themes of ASMS 2026

The 74th Annual ASMS Conference drew an estimated 6300 to 7000 scientists to San Diego for a five-day program of oral sessions, roughly 3000 poster presentations, workshops, and one of the most active exhibit floors in the conference's history. The scientific program was organized around eight application tracks—proteomics, metabolomics, biopharma, environmental and food safety, clinical, structural biology, multiomics, and data science—and the technical themes that emerged across all of them tell a coherent story about where mass spectrometry is heading as a discipline.

The AI Inflection Point

Artificial intelligence (AI) moved from aspirational language to concrete product features at ASMS 2026. The shift was visible everywhere: in new instrument firmware, in software launches, and in the language/terminology companies used to differentiate their platforms.

Thermo Fisher Scientific made the clearest statement of intent by acquiring two AI-focused software companies—MSAID and Proteinaceous—and showcasing both at the conference. MSAID brings machine-learning-driven peptide identification and spectral interpretation; Proteinaceous adds bioinformatics for top-down and native mass spectrometry. Their combined integration into the Orbitrap (orbital trap) ecosystem, alongside the new Proteoform Studio software and Proteome Discoverer 3.4, signals that AI-assisted data interpretation is now considered an essential component to the instrument. Shimadzu's LCMS-8065XE features an AI Performance Concierge for predictive maintenance and Peakintelligence for automated peak detection, claiming 67% reduction in manual data review time. Sciex OS 5.0 added an AI-enabled help function and AI-driven Calculated Columns to the ZenoTOF platform.

Beyond individual instrument vendors, mzio GmbH announced the launch of FAIR-MS at ASMS 2026, an initiative to apply AI to the reuse and comparative analysis of historical mass spectrometry data across instruments, laboratories, and measurement conditions, a vendor-agnostic approach to unlocking the value held in archived datasets. The project, developed in collaboration with Sciex, Waters, Agilent, and Bruker, points toward a future in which the scientific value of MS data extends far beyond the original experiment.

The Sensitivity and Speed Arms Race in Proteomics

The proteomics instrumentation battle intensified at ASMS 2026, with the major vendors each pressing their claims for deeper proteome coverage at faster acquisition speeds and from smaller sample inputs.

Thermo Fisher's Orbitrap Tribrid Apex arrived with aggressive performance claims: five times greater sensitivity than the previous-generation Tribrid, up to 100% sequence coverage in a single experiment, and results four times faster. The instrument incorporates three mass analyzers on a single platform alongside a new infrared laser option for alternative fragmentation and Direct Mass Technology Mode. Bruker launched the timsMRMS, combining trapped ion mobility spectrometry (TIMS) with magnetic resonance mass spectrometry, and announced advances in its 4D proteomics performance and functional proteoform analysis. Waters entered the conversation with the Xevo MRT P10, a benchtop quadrupole time-of-flight (QTOF) claiming 20x improvement in MS/MS sensitivity over its predecessor and identification of 40% more lipids than leading competing benchtop instruments.

Poster sessions reinforced the theme. Presentations featured data-independent acquisition (DIA), workflows on the Orbitrap Astral Zoom for deep metaproteomic profiling of environmental microbial communities, single-cell proteomics approaches for mapping human brain development, and formalin-fixed, paraffin-embedded (FFPE) tissue proteomics using Orbitrap platforms with high-field asymmetric waveform ion mobility spectrometry (FAIMS). The central question across all of these presentations was not whether deep proteomics was possible, but how to make it routine, reproducible, and scalable.

Spatial and Structural Biology Go Mainstream

Spatial omics, the ability to map molecular information onto tissue architecture, continued its rapid ascent as an ASMS theme. Waters' cyclic ion mobility spectrometry (IMS) P20, one of the most talked-about instrument launches of the week, integrates multipass cyclic ion mobility with matrix-assisted laser desorption/ionization (MALDI) XS and desorption electrospray ionization (DESI) XS imaging sources to visualize molecules within tissue at high resolution in a single experiment. The company positioned the instrument explicitly around early disease detection: from protein misfolding to post-translational modification mapping in cellular context.

Bruker's workshop program included an entire track on translational spatial omics, from tissue to clinical decision, alongside a session on advancing structural analysis with Omnitrap technology. The growing overlap between spatial biology tools developed for genomics and single-cell transcriptomics on one side, and mass spectrometry imaging on the other, was a recurring discussion point. Ion mobility spectrometry, particularly the TIMS technology in the Bruker timsTOF family and the Cyclic IMS approach in Waters instruments, has become the enabling link, separating isomeric compounds and adding a conformational dimension that neither MS nor genomics tools can achieve alone.

New Modalities, New Analytical Demands in Biopharma

GLP-1 receptor agonists, oligonucleotides, antibody-drug conjugates (ADCs), and gene therapy vectors dominated the biopharma sessions, reflecting the therapeutic pipeline that pharmaceutical scientists are now being asked to characterize. Each modality presents distinct analytical challenges that conventional liquid chromatography–mass spectrometry (LC–MS) platforms were not originally designed to handle.

Thermo Fisher's Orbitrap Excedion was designed with this challenge explicitly in mind, claiming three to five times more compound detection in complex matrices via enhanced dynamic range technology, a direct response to the sensitivity tradeoffs that arise when analyzing oligonucleotides or ADC payloads in biological matrices. Genedata highlighted fully automated mRNA mapping for MS/MS-based product quality attribute analysis as a session focus, reflecting the growing role of nucleic acid MS in quality control for RNA therapeutics. Sciex's ZenoTOF platform expansion, with Echo MS+ integration for one-sample-per-second accurate mass screening and HDX-MS through Trajan, addressed the need for higher-throughput structural characterization earlier in the development process.

Environmental Monitoring at Scale: PFAS and Emerging Contaminants

Per- and polyfluoroalkyl substances (PFAS) analysis was the dominant applied science theme at ASMS 2026, reflecting years of regulatory momentum and the ongoing expansion of safety monitoring requirements globally. Multiple major vendors featured PFAS workflows prominently. Thermo Fisher introduced the Orbitrap Exploris GC S, a high-resolution gas chromatography–mass spectrometry (GC–MS) platform for dioxins and persistent organic pollutants (POPs), and the Orbitrap Exploris EFOX for high-resolution mass spectrometry (HRMS)-based contaminant screening. Shimadzu emphasized the LCMS-8065XE's sub-ng/L PFAS detection limits in drinking water using direct injection. Bruker's Contaminant Analysis breakfast workshop addressed PFAS, POPs, and emerging contaminants through the timsMetabo platform.

The broader theme was movement toward high-resolution accurate mass approaches for environmental monitoring, replacing or supplementing targeted triple-quadrupole methods with instruments capable of both quantitation and retrospective screening from a single data file—a capability that regulators and public health agencies are increasingly requesting as the list of regulated contaminants expands.

Sustainability as a Differentiator

A quieter but consistent theme across the exhibit floor was sustainability. Shimadzu's LCMS-8065XE led with specific numbers: 31% lower power consumption and 63% lower running costs than competitive systems. Sciex's novus V55 highlighted 40% reductions in both energy consumption and laboratory cooling requirements alongside its smaller footprint. Agilent's 8890B/8860B GC systems incorporated GC Assist monitoring and diagnostics aimed at reducing unplanned downtime. These were not the headline stories of ASMS 2026, but the consistency with which sustainability metrics appeared in product literature suggests the industry is responding to real laboratory and procurement pressures—and recognizes that operational cost and environmental footprint are increasingly part of the purchase decision.

Report prepared June 2, 2026, based on press releases, exhibitor announcements, and scientific program materials from the 74th ASMS Annual Conference.